425 related articles for article (PubMed ID: 33176148)
1. ARID1A Mutations Promote P300-Dependent Endometrial Invasion through Super-Enhancer Hyperacetylation.
Wilson MR; Reske JJ; Holladay J; Neupane S; Ngo J; Cuthrell N; Wegener M; Rhodes M; Adams M; Sheridan R; Hostetter G; Alotaibi FT; Yong PJ; Anglesio MS; Lessey BA; Leach RE; Teixeira JM; Missmer SA; Fazleabas AT; Chandler RL
Cell Rep; 2020 Nov; 33(6):108366. PubMed ID: 33176148
[TBL] [Abstract][Full Text] [Related]
2. ARID1A and PGR proteins interact in the endometrium and reveal a positive correlation in endometriosis.
Kim HI; Kim TH; Yoo JY; Young SL; Lessey BA; Ku BJ; Jeong JW
Biochem Biophys Res Commun; 2021 Apr; 550():151-157. PubMed ID: 33706098
[TBL] [Abstract][Full Text] [Related]
3. ARID1A-dependent maintenance of H3.3 is required for repressive CHD4-ZMYND8 chromatin interactions at super-enhancers.
Reske JJ; Wilson MR; Armistead B; Harkins S; Perez C; Hrit J; Adams M; Rothbart SB; Missmer SA; Fazleabas AT; Chandler RL
BMC Biol; 2022 Sep; 20(1):209. PubMed ID: 36153585
[TBL] [Abstract][Full Text] [Related]
4. ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion.
Wilson MR; Reske JJ; Holladay J; Wilber GE; Rhodes M; Koeman J; Adams M; Johnson B; Su RW; Joshi NR; Patterson AL; Shen H; Leach RE; Teixeira JM; Fazleabas AT; Chandler RL
Nat Commun; 2019 Aug; 10(1):3554. PubMed ID: 31391455
[TBL] [Abstract][Full Text] [Related]
5. SWI/SNF inactivation in the endometrial epithelium leads to loss of epithelial integrity.
Reske JJ; Wilson MR; Holladay J; Wegener M; Adams M; Chandler RL
Hum Mol Genet; 2020 Dec; 29(20):3412-3430. PubMed ID: 33075803
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells.
Lakshminarasimhan R; Andreu-Vieyra C; Lawrenson K; Duymich CE; Gayther SA; Liang G; Jones PA
Cancer Lett; 2017 Aug; 401():11-19. PubMed ID: 28483516
[TBL] [Abstract][Full Text] [Related]
7. Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis.
Reske JJ; Wilson MR; Holladay J; Siwicki RA; Skalski H; Harkins S; Adams M; Risinger JI; Hostetter G; Lin K; Chandler RL
PLoS Genet; 2021 Dec; 17(12):e1009986. PubMed ID: 34941867
[TBL] [Abstract][Full Text] [Related]
8. Endometrial epithelial ARID1A is critical for uterine gland function in early pregnancy establishment.
Marquardt RM; Kim TH; Yoo JY; Teasley HE; Fazleabas AT; Young SL; Lessey BA; Arora R; Jeong JW
FASEB J; 2021 Feb; 35(2):e21209. PubMed ID: 33222288
[TBL] [Abstract][Full Text] [Related]
9. ARID1A, Prostaglandin E2, and Its Receptor as Possible Predictors of Malignant Transformation of the Endometrium in Endometriosis.
Dyatlova AS; Lin'kova NS; Polyakova VO; Samoshkin NG; Kvetnoi IM
Bull Exp Biol Med; 2019 Aug; 167(4):504-507. PubMed ID: 31494765
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming.
Suryo Rahmanto Y; Shen W; Shi X; Chen X; Yu Y; Yu ZC; Miyamoto T; Lee MH; Singh V; Asaka R; Shimberg G; Vitolo MI; Martin SS; Wirtz D; Drapkin R; Xuan J; Wang TL; Shih IM
Nat Commun; 2020 Jun; 11(1):2717. PubMed ID: 32483112
[TBL] [Abstract][Full Text] [Related]
11. Endometrial Epithelial ARID1A Is Required for Uterine Immune Homeostasis during Early Pregnancy.
Marquardt RM; Ahn SH; Reske JJ; Chandler RL; Petroff MG; Kim TH; Jeong JW
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682747
[TBL] [Abstract][Full Text] [Related]
12. AP-1 Subunit JUNB Promotes Invasive Phenotypes in Endometriosis.
Wilson MR; Reske JJ; Chandler RL
Reprod Sci; 2022 Nov; 29(11):3266-3277. PubMed ID: 35616875
[TBL] [Abstract][Full Text] [Related]
13. ARID1A-dependent permissive chromatin accessibility licenses estrogen-receptor signaling to regulate circadian rhythms genes in endometrial cancer.
Hu H; Chen Z; Ji L; Wang Y; Yang M; Lai R; Zhong Y; Zhang X; Wang L
Cancer Lett; 2020 Nov; 492():162-173. PubMed ID: 32858102
[TBL] [Abstract][Full Text] [Related]
14. Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.
Kelso TWR; Porter DK; Amaral ML; Shokhirev MN; Benner C; Hargreaves DC
Elife; 2017 Oct; 6():. PubMed ID: 28967863
[TBL] [Abstract][Full Text] [Related]
15. ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells.
Sen M; Wang X; Hamdan FH; Rapp J; Eggert J; Kosinsky RL; Wegwitz F; Kutschat AP; Younesi FS; Gaedcke J; Grade M; Hessmann E; Papantonis A; Strӧbel P; Johnsen SA
Clin Epigenetics; 2019 Jun; 11(1):92. PubMed ID: 31217031
[TBL] [Abstract][Full Text] [Related]
16. Histopathology and ARID1A Expression in Endometriosis- Associated Ovarian Carcinoma (EAOC) Carcinogenesis Model with Endometrial Autoimplantation and DMBA Induction.
Wuyung PE; Rahadiati FB; Tjahjadi H; Salinah S; Kusmardi K; Kodariah R; Wiweko B
Asian Pac J Cancer Prev; 2021 Feb; 22(2):553-558. PubMed ID: 33639673
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species downregulate ARID1A expression via its promoter methylation during the pathogenesis of endometriosis.
Xie H; Chen P; Huang HW; Liu LP; Zhao F
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4509-4515. PubMed ID: 29131266
[TBL] [Abstract][Full Text] [Related]
18. The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers.
Alver BH; Kim KH; Lu P; Wang X; Manchester HE; Wang W; Haswell JR; Park PJ; Roberts CW
Nat Commun; 2017 Mar; 8():14648. PubMed ID: 28262751
[TBL] [Abstract][Full Text] [Related]
19. The chromatin Remodeler CHD8 is required for activation of progesterone receptor-dependent enhancers.
Ceballos-Chávez M; Subtil-Rodríguez A; Giannopoulou EG; Soronellas D; Vázquez-Chávez E; Vicent GP; Elemento O; Beato M; Reyes JC
PLoS Genet; 2015 Apr; 11(4):e1005174. PubMed ID: 25894978
[TBL] [Abstract][Full Text] [Related]
20. ARID1A mutations in endometriosis-associated ovarian carcinomas.
Wiegand KC; Shah SP; Al-Agha OM; Zhao Y; Tse K; Zeng T; Senz J; McConechy MK; Anglesio MS; Kalloger SE; Yang W; Heravi-Moussavi A; Giuliany R; Chow C; Fee J; Zayed A; Prentice L; Melnyk N; Turashvili G; Delaney AD; Madore J; Yip S; McPherson AW; Ha G; Bell L; Fereday S; Tam A; Galletta L; Tonin PN; Provencher D; Miller D; Jones SJ; Moore RA; Morin GB; Oloumi A; Boyd N; Aparicio SA; Shih IeM; Mes-Masson AM; Bowtell DD; Hirst M; Gilks B; Marra MA; Huntsman DG
N Engl J Med; 2010 Oct; 363(16):1532-43. PubMed ID: 20942669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]